Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 48 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	S-1 and Cisplatin or Fluorouracil and Cisplatin in Treating Patients With Locally Advanced or Metastatic Gastric Cancer That Cannot Be Removed By Surgery				Phase III				TAIHO-TPU-S1301 QUINT-TPU-S1301, NCT00400179
	LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib				Phase III				EGF110656 EGF110656-TRIO-CIRG 013, NCT00680901
	Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib				Phase III				IPI-504-06 NCT00688766
	Erlotinib and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer				Phase II, Phase I				VU-VICC-GI-0622 VICC-GI-0622, 6980, NCI-6980, NCT00397384
	Low Dose Radiation Therapy as Chemosensitizer in GI/ Ovarian Tumors				Phase II, Phase I				22706 NCT00390182
	Evaluation of Single Session Stereotactic Body Radiotherapy				Phase II, Phase I				2005-0445 NCT00492817
	Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors				Phase II, Phase I				CTCT 06-11 NCT00493883
	Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)				Phase II, Phase I				ID02-446 NCT00508443
	Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients				Phase II, Phase I				2004-0290 NCT00526110
	Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer				Phase II, Phase I				Pro00002207 SPS 151596, NCT00578071


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute